Modern possibilities of the diagnosing of primary hyperparathyroidism
- Authors: Boriskova M.E.1, Pankova P.A.1, Khamid L.A.1, Bykov M.A.1, Zuykevich D.V.1, Valiakhmedova K.V.2, Ulimbasheva Z.M.1, Pogosy0an K.A.3, Karonova T.L.3, Ryzhkova D.V.3
-
Affiliations:
- Pavlov First Saint Petersburg State Medical University
- My Medical Center Group
- Almazov National Medical Research Centre
- Issue: Vol 27, No 4 (2025): Эндокринология
- Pages: 223-228
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/309765
- DOI: https://doi.org/10.26442/20751753.2025.4.203317
- ID: 309765
Cite item
Full Text
Abstract
Background. Currently, the most common method of preoperative imaging of affected parathyroid glands (PTG) is a combination of scintigraphy with technetium [99mTc] sestamibi and neck ultrasound (with a sensitivity of 81–95%). In some cases, such as multiple PTG lesions, their ectopic location, multiple nodular thyroid lesions, and their hyperfunction or inflammation, standard imaging methods may show negative or contradictory results, which requires the use of 2nd-line diagnostic studies. One is positron emission tomography combined with computed tomography (PET/CT) with 11C-choline.
Aim. To determine the role of PET/CT with 11C-choline in the topical diagnosis of primary hyperparathyroidism.
Materials and methods. Retrospective analysis of data from 33 patients with primary hyperparathyroidism who underwent parathyroidectomy at the Department of Surgical Endocrinology of Pavlov First Saint Petersburg State Medical University from 2022 to 2024. Due to the ineffectiveness of standard imaging and/or the persistence of primary hyperparathyroidism after the first surgery, all patients included in the study underwent PET/CT with 11C-choline (Almazov National Medical Research Centre). The accuracy, sensitivity, specificity, and positive and negative predictive values were calculated considering the pathological postoperative verification of adenoma/hyperplasia and/or achievement of the reference range of parathyroid hormone and calcium plasma levels.
Results. A total of 41 masses were removed in 33 patients (8 patients had 2 masses removed each). Thirty-seven areas were positive according to PET/CT with 11C-choline. Its diagnostic accuracy was 95.5%, sensitivity 90.2%, specificity 97.8%, positive predictive value 94.9%, and negative predictive value 95.7%.
Conclusion. PET/CT with 11C-choline demonstrated high efficacy in preoperative localization assessment of PTG adenomas, even in cases where the results of first-line imaging methods were ambiguous. We use this method in complex cases, although it can be considered an alternative to first-line imaging. This question remains open and requires further studies comparing economic feasibility.
Full Text
##article.viewOnOriginalSite##About the authors
Marina E. Boriskova
Pavlov First Saint Petersburg State Medical University
Author for correspondence.
Email: boriskovam@gmail.com
ORCID iD: 0000-0002-0037-6222
D. Sci. (Med.), Prof., Head of Department
Polina A. Pankova
Pavlov First Saint Petersburg State Medical University
Email: boriskovam@gmail.com
ORCID iD: 0000-0002-6909-1858
Cand. Sci. (Med.), Assist.
Lina A. Khamid
Pavlov First Saint Petersburg State Medical University
Email: boriskovam@gmail.com
ORCID iD: 0009-0004-7557-1809
Student
Russian Federation, Saint PetersburgMikhail A. Bykov
Pavlov First Saint Petersburg State Medical University
Email: boriskovam@gmail.com
ORCID iD: 0000-0001-6806-1414
Cand. Sci. (Med.), Surgeon
Russian Federation, Saint PetersburgDaria V. Zuykevich
Pavlov First Saint Petersburg State Medical University
Email: boriskovam@gmail.com
ORCID iD: 0000-0002-7951-7402
Lab. Assist.
Russian Federation, Saint PetersburgKristina V. Valiakhmedova
My Medical Center Group
Email: boriskovam@gmail.com
ORCID iD: 0000-0001-5120-1142
Surgeon
Russian Federation, Saint PetersburgZalina M. Ulimbasheva
Pavlov First Saint Petersburg State Medical University
Email: boriskovam@gmail.com
ORCID iD: 0000-0002-2097-2881
Cand. Sci. (Med.), Surgeon
Russian Federation, Saint PetersburgKarina A. Pogosy0an
Almazov National Medical Research Centre
Email: boriskovam@gmail.com
ORCID iD: 0000-0003-0628-0085
Jun. Res.
Russian Federation, Saint PetersburgTatiana L. Karonova
Almazov National Medical Research Centre
Email: boriskovam@gmail.com
ORCID iD: 0000-0002-1547-0123
D. Sci. (Med.), Head of Laboratory, Chief Res.
Russian Federation, Saint PetersburgDaria V. Ryzhkova
Almazov National Medical Research Centre
Email: boriskovam@gmail.com
ORCID iD: 0000-0002-7086-9153
D. Sci. (Med.), Prof., Head of Department
Russian Federation, Saint PetersburgReferences
- Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3561-9. doi: 10.1210/jc.2014-1413
- Felger EA, Kandil E. Primary hyperparathyroidism. Otolaryngol Clin North Am. 2010;43(2):417-32. doi: 10.1016/j.otc.2010.01.009
- Insogna KL. Primary Hyperparathyroidism. N Engl J Med. 2018;379(11):1050-9. doi: 10.1056/NEJMcp1714213
- DeLellis RA, Mazzaglia P, Mangray S. Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med. 2008;132(8):1251-62. doi: 10.5858/2008-132-1251-PHACP
- Lloyd RV, Osamura RY, Klöppel G, Rosai J. WHO Classification of Tumours of Endocrine Organs. Lyon, France: International Agency for Research on Cancer, 2017.
- Morris MA, Saboury B, Ahlman M, et al. Parathyroid Imaging: Past, Present, and Future. Front Endocrinol (Lausanne). 2022;25;12:760419. doi: 10.3389/fendo.2021.760419
- Sukan A, Reyhan M, Aydin M, et al. Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging. Ann Nucl Med. 2008;22(2):123-31. doi: 10.1007/s12149-007-0086-z
- Patel CN, Salahudeen HM, Lansdown M, Scarsbrook AF. Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism. Clin Radiol. 2010;65(4):278-87. doi: 10.1016/j.crad.2009.12.005
- Hodolic M, Huchet V, Balogova S, et al. Incidental uptake of (18)F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer. Radiol Oncol. 2014;48(3):228-34. doi: 10.2478/raon-2013-0075
- Khokar AM, Kuchta KM, Moo-Young TA, et al. Increasing trend of bilateral neck exploration in primary hyperparathyroidism. Am J Surg. 2020;219(3):466-70. doi: 10.1016/j.amjsurg.2019.09.039
- Chakrabarty N, Mahajan A, Basu S, D'Cruz AK. Imaging Recommendations for Diagnosis and Management of Primary Parathyroid Pathologies: A Comprehensive Review. Cancers (Basel). 2024;16(14):2593. doi: 10.3390/cancers16142593
- Gough I (2006) Reoperative parathyroid surgery: the importance of ectopic location and multigland disease. ANZ J Surg. 76:1048-50. doi: 10.1111/j.1445-2197.2006.03931.x
- Jaskowiak N, Norton JA, Alexander HR, et al. A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma. Ann Surg. 1996;224:308-20. doi: 10.1097/00000658-199609000-00007
- Bergenfelz AO, Wallin G, Jansson S, et al. Results of surgery for sporadic primary hyperparathyroidism in patients with preoperatively negative sestamibi scintigraphy and ultrasound. Langenbeck’s Arch Surg. 2011;396:83-90. doi: 10.1007/s00423-010-0724-0
- Parikh PP, Farra JC, Allan BJ, et al. Long-term effectiveness of localization studies and intraoperative parathormone monitoring in patients undergoing reoperative parathyroidectomy for persistent or recurrent hyperparathyroidism. Am J Surg. 2015;210:117-22 doi: 10.1016/j.amjsurg.2014.09.039
- Karakas E, Muller HH, Schlosshauer T, et al. Reoperations for primary hyperparathyroidism –improvement of outcome over two decades. Langenbeck’s Arch Surg. 2013;398:99-106. doi: 10.1007/s00423-012-1004-y
- Мокрышева Н.Г., Еремкина А.К., Мирная С.С., и др. Клинические рекомендации по первичному гиперпаратиреозу, краткая версия. Проблемы эндокринологии. 2021;4. Режим доступа: https://cyberleninka.ru/article/n/klinicheskie-rekomendatsii-po-pervichnomu-giperparatireozu-kratkaya-versiya. Ссылка активна на 12.02.2025 [Mokrysheva NG, Eremkina AK, Mirnaia SS, et al. Klinicheskie rekomendatsii po pervichnomu giperparatireozu, kratkaia versiia. Problemy endokrinologii. 2021;4. Available at: https://cyberleninka.ru/article/n/klinicheskie-rekomendatsii-po-pervichnomu-giperparatireozu-kratkaya-versiya. Accessed: 12.02.2025 (in Russian)]. doi: 10.14341/probl12801
- Животов В.А., Дрожжин А.Ю., Ветшев П.С. Топическая диагностика поражений околощитовидных желез. Вестник Национального медико-хирургического центра им. Н.И. Пирогова. 2017;4-2. Режим доступа: https://cyberleninka.ru/article/n/topicheskaya-diagnostika-porazheniy-okoloschitovidnyh-zhelez. Ссылка активна на 12.02.2025 [Zhivotov VA, Drozhzhin AIu, Vetshev PS. Topicheskaia diagnostika porazhenii okoloshchitovidnykh zhelez. Vestnik Natsionalnogo mediko-khirurgicheskogo tsentra im. N.I. Pirogova. 2017;4-2. Available at: https://cyberleninka.ru/article/n/topicheskaya-diagnostika-porazheniy-okoloschitovidnyh-zhelez Accessed: 12.02.2025 (in Russian)].
- Zafereo M, Yu J, Angelos P, Brumund K, et al. American Head and Neck Society Endocrine Surgery Section update on parathyroid imaging for surgical candidates with primary hyperparathyroidism. Head Neck. 2019;41(7):2398-409. doi: 10.1002/hed.25781
- Petranović Ovčariček P, Giovanella L, Carrió Gasset I, et al. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021;48(9):2801-22. doi: 10.1007/s00259-021-05334-y
- Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235(5):665-70. doi: 10.1097/00000658-200205000-00008
- Harari A, Mitmaker E, Grogan RH, et al. Primary hyperparathyroidism patients with positive preoperative sestamibi scan and negative ultrasound are more likely to have posteriorly located upper gland adenomas (PLUGs). Ann Surg Oncol. 2011;18(6):1717-22. doi: 10.1245/s10434-010-1493-2
- Zhang Z, Zhao M, Chen B, et al. Comparative Analysis of Diagnostic Efficacy in Primary Hyperparathyroidism: A Comparison Analysis of 11C-Choline PET/CT, Neck Ultrasonography, 99mTc-MIBI Dual-Phase Planar Scintigraphy, and 99mTc-MIBI SPECT/CT Imaging. J Cancer. 2024;15(7):1863-9. doi: 10.7150/jca.91483
- Orevi M, Freedman N, Mishani E, et al. Localization of parathyroid adenoma by ¹¹C-choline PET/CT: preliminary results. Clin Nucl Med. 2014;39(12):1033-8. doi: 10.1097/RLU.0000000000000607
- Ismail A, Christensen JW, Krakauer M, et al. 11C-Choline PET/CT vs. 99mTc-MIBI/123Iodide Subtraction SPECT/CT for Preoperative Detection of Abnormal Parathyroid Glands in Primary Hyperparathyroidism: A Prospective, Single-Centre Clinical Trial in 60 Patients. Diagnostics (Basel). 2020;10(11):975. doi: 10.3390/diagnostics10110975
- Liu Y, Dang Y, Huo L, et al. Preoperative Localization of Adenomas in Primary Hyperparathyroidism: The Value of 11C-Choline PET/CT in Patients with Negative or Discordant Findings on Ultrasonography and 99mTc-Sestamibi SPECT/CT. J Nucl Med. 2020;61(4):584-9. doi: 10.2967/jnumed.119.233213
- Погосян К.А., Каронова Т.Л., Рыжкова Д.В., и др. Сравнение ПЭТ/КТ С 11С-метионином и 11С-холином при визуализации аденом околощитовидных желез: проспективное исследование. Лучевая диагностика и терапия. 2024;15(2):45-52 [Pogosian KА, Karonova TL, Ryzhkova DV, et al. Comparision of 11C-methionine and 11C-choline pet/ct for parathyroid visualization: a prospective study. Diagnostic radiology and radiotherapy. 2024;15(2):45-52 (in Russian)]. doi: 10.22328/2079-5343-2024-15-2-45-52
- Parvinian A, Martin-Macintosh EL, Goenka AH, et al. 11C-Choline PET/CT for Detection and Localization of Parathyroid Adenomas. AJR Am J Roentgenol. 2018;210(2):418-22. doi: 10.2214/AJR.17.18312
Supplementary files
